Main > ENDOCRINOLOGY > Diabetes. Prevn > Lipase Inhibitors. > Orlistat. > Clinical Study

Product CH. R

CLINICAL STUDY 3.304 individuals took part in study. The ones who took orlistat have a 37% lower risk of developing diabetes type 2.
UPDATE 08.02
COMPANY This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back